Castle Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	62.12	116.73	119.71	98.84	122.95	329.63
Short-Term Investments	204.69	182.78	173.42	144.26	135.68	-
Cash & Short-Term Investments	266.81	299.51	293.13	243.1	258.63	329.63
Cash Growth	-3.31%	2.17%	20.58%	-6.00%	-21.54%	-19.57%
Accounts Receivable	48.34	43.38	51.22	38.3	23.48	17.28
Other Receivables	1.4	1.1	0.6	-	-	-
Receivables	49.74	44.48	51.82	38.3	23.48	17.28
Inventory	10.58	10.25	8.14	7.94	3.98	2.02
Prepaid Expenses	13.97	6.86	7.07	6.29	6.21	4.81
Total Current Assets	341.1	361.1	360.15	295.64	292.29	353.74
Property, Plant & Equipment	118.88	112.24	62.71	37.74	26.5	16.88
Goodwill	10.69	10.69	10.69	10.69	10.69	-
Other Intangible Assets	84.4	88.88	95.54	106.64	115.66	88.92
Other Long-Term Assets	6.1	5.65	2.15	2.63	2.2	3.02
Total Assets	561.18	578.56	531.24	453.34	447.33	462.57
Accounts Payable	9.67	18.71	6.9	10.27	4.73	2.55
Accrued Expenses	34.41	45.1	38.7	35.26	29.21	20.5
Current Portion of Long-Term Debt	2.92	0.42	0.28	-	-	-
Current Portion of Leases	1.42	1.43	1.77	1.21	1.93	1.28
Current Income Taxes Payable	-	-	-	0.4	-	-
Other Current Liabilities	8.09	3.02	1.75	0.54	0.27	0.56
Total Current Liabilities	56.51	68.68	49.39	47.67	36.13	24.89
Long-Term Debt	7.16	9.64	9.75	-	-	-
Long-Term Leases	25.16	25.53	14.66	14.2	11.62	7.02
Long-Term Deferred Tax Liabilities	2.32	2.34	1.61	0.21	0.43	0.64
Other Long-Term Liabilities	-	1.5	-	-	-	18.29
Total Liabilities	91.15	107.68	75.4	62.07	48.18	50.83
Common Stock	0.03	0.03	0.03	0.03	0.03	0.03
Additional Paid-In Capital	711.12	694.86	655.7	609.48	560.41	505.48
Retained Earnings	-240.87	-224.28	-200.13	-218.37	-160.91	-93.77
Comprehensive Income & Other	-0.26	0.27	0.23	0.14	-0.38	-
Total Common Equity	470.03	470.87	455.84	391.27	399.15	411.74
Shareholders' Equity	470.03	470.87	455.84	391.27	399.15	411.74
Total Liabilities & Equity	561.18	578.56	531.24	453.34	447.33	462.57
Total Debt	36.65	37.02	26.45	15.41	13.55	8.31
Net Cash (Debt)	230.16	262.49	266.69	227.69	245.08	321.33
Net Cash Growth	-3.53%	-1.57%	17.13%	-7.09%	-23.73%	-21.60%
Net Cash Per Share	7.75	9.06	9.12	8.50	9.41	12.78
Filing Date Shares Outstanding	30.55	29.73	28.51	27.45	26.58	25.41
Total Common Shares Outstanding	30.51	29.69	28.48	27.41	26.55	25.38
Working Capital	284.59	292.42	310.76	247.97	256.16	328.86
Book Value Per Share	15.41	15.86	16.00	14.27	15.03	16.22
Tangible Book Value	374.93	371.3	349.61	273.93	272.8	322.82
Tangible Book Value Per Share	12.29	12.51	12.27	9.99	10.27	12.72
Land	7.25	7.25	7.25	-	-	-
Machinery	47.13	42.6	32.48	22.92	15.35	7.47
Construction In Progress	12.58	51.06	9.61	0.64	1.28	0.03
Leasehold Improvements	14.92	14.83	14.62	9.99	5.17	5.04

SEC Filings: 10-K · 10-Q